Original Dutch text by Remco Zuiderent (Fortelle)
A practical approach to cardiac PET/CT
SPECT/CT is the most common nuclear medicine imaging modality used to visualize blood circulation in the heart; however, in an increasing number of locations, facilities are switching to PET/CT. The Northwest Clinics in the Netherlands has been one of the region’s pioneers in deploying cardiac PET/CT on a large-scale clinical basis.
The convergence of nuclear medicine and musculoskeletal medicine has many benefits, particularly in orthopedic surgery. The capabilities of SPECT/CT technology, combined with advanced reconstruction and reading solutions, allow for accurate localization of pain origins that support diagnostic confidence and surgical accuracy.
Image of the Year and Paper of the Year are two of SNMMI’s most prestigious awards, granted to researchers who demonstrate promising advances in nuclear medicine and molecular imaging. The awards, as well as the latest developments in research and technology, were showcased at this year’s reimagined virtual 2020 conference.
Given the ever-changing healthcare landscape—one that is now even more fluid and volatile since the arrival of SARS-CoV-2—education and collaboration between nuclear medicine professionals and their colleagues are key to expanding and optimizing nuclear medicine’s utilization.
The treatment of musculoskeletal pain is a precise practice that requires accurate localization of possible pain generators. Given SPECT/CT's intrinsic anatomical and physiological imaging properties, it is an ideal choice in helping musculoskeletal medicine practitioners locate pain origins and develop effective treatment plans.
Hildegard Kaulen, PhD
Photography by Carsten Büll
Gallium-68 and fluorine-18-labeled PSMA ligands, imaged using PET/CT, are set to become a useful tool for primary staging and recurrence diagnosis in prostate cancer.
Photography by Alex Teuscher | Illustration by Clint Poy
SPECT/CT imaging is a ubiquitous tool that aides clinicians in making prompt diagnoses and developing personalized treatment strategies. With the addition of an automated tool that consistently produces reliable, quantitative measurements, providers explain how they are able to integrate quantification into their routine SPECT/CT protocols.
Univ.-Prof. Dr. Marcus Hacker
Our new column “Point of View” picks up trends and developments in healthcare. In this edition, Univ.-Prof. Dr. Marcus Hacker comments on the potential of AI in molecular imaging.
Photography by Ronald Patrick
At Siemens Healthineers’ recent Molecular Imaging World Summit, nuclear medicine and molecular imaging professionals were optimistic about the future as they examined trends, research, and technological advancements.The Summit fostered inspired discussion around opportunities for molecular imaging.
Photography by Miquel Gonzalez
In molecular imaging, the smallest details can make a significant difference when it comes to reporting, sharing, and reading studies. By equipping their nuclear medicine and molecular imaging department with a revolutionary reading solution, Instituut Verbeeten in the Netherlands aims to deliver accurate and efficient medical care.
Data courtesy of Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
By Misty Long, R.T. (R)(N)
Data courtesy of Dr. Saima Muzahir, MD, Erlanger Health System, Chattanooga, TN, USA
An 84-year-old male with a more than 60 year history of tobacco use, previously diagnosed with squamous cell carcinoma of the oral cavity undergoes a PET/CT for subsequent treatment strategy with the aid of technologies like iMAR and FlowMotion™.
PET/CT reveals recurrent disease in patients with head and neck cancers
Colleen R. Smith, MBA
Photography by Alex Teuscher
SPECT/CT imaging is invaluable as we move toward precision medicine, and the significant addition of reliable quantitative measurements only enhances SPECT/CT’s opportunities. But as quantitative SPECT/CT looks to establish an active role in the next era of healthcare, the extent of its impact continues to be defined.